TRVN (OTC)
TREVENA INC
$0.011100
+0.000000 (+0.00%)
Prev close: $0.011100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Carrie L. Bourdow
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $1.93M
- Employees
- 43
- P/E (TTM)
- —
- P/B (TTM)
- 0.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-5.79 | $-7.47 | +1.6815 | +22.51% |
|
Jun 2024 (Q2)
|
$-5.75 | $-10.33 | +4.5775 | +44.32% |
|
Mar 2024 (Q1)
|
$-9.00 | $-11.99 | +2.9850 | +24.91% |
|
Dec 2023 (Q4)
|
$-26.50 | $-9.65 | -16.8482 | -174.56% |
Financial Statements
| Revenues | $546.00K |
| Benefits Costs and Expenses | $32.71M |
| Cost Of Revenue | $1.59M |
| Costs And Expenses | $32.65M |
| Gross Profit | -$1.04M |
| Nonoperating Income/Loss | -$1.93M |
| Operating Expenses | $31.07M |
| Research and Development | $13.13M |
| Other Operating Expenses | $17.93M |
| Operating Income/Loss | -$32.11M |
| Income/Loss From Continuing Operations After Tax | -$34.04M |
| Income/Loss From Continuing Operations Before Tax | -$32.16M |
| Interest Expense, Operating | $2.90M |
| Net Income/Loss | -$34.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$47.00K |
| Net Income/Loss Attributable To Parent | -$33.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $47.00K |
| Preferred Stock Dividends And Other Adjustments | $47.00K |
| Basic Earnings Per Share | $41.11 |
| Diluted Earnings Per Share | $41.11 |
| Basic Average Shares | 34,429,434 |
| Diluted Average Shares | 34,429,434 |
| Assets | $19.19M |
| Current Assets | $14.74M |
| Noncurrent Assets | $4.45M |
| Fixed Assets | $923.00K |
| Other Non-current Assets | $3.53M |
| Liabilities | $42.50M |
| Current Liabilities | $6.09M |
| Accounts Payable | $918.00K |
| Other Current Liabilities | $5.17M |
| Noncurrent Liabilities | $36.41M |
| Equity | -$23.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$23.31M |
| Liabilities And Equity | $19.19M |
| Net Cash Flow From Operating Activities | -$27.09M |
| Net Cash Flow From Operating Activities, Continuing | -$27.09M |
| Net Cash Flow From Investing Activities | $19.41M |
| Net Cash Flow From Investing Activities, Continuing | $19.41M |
| Net Cash Flow From Financing Activities | $5.70M |
| Net Cash Flow From Financing Activities, Continuing | $5.70M |
| Net Cash Flow | -$1.98M |
| Net Cash Flow, Continuing | -$1.98M |
| Comprehensive Income/Loss | -$34.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.04M |
| Other Comprehensive Income/Loss | $0.00 |